Kaleyra . Quarterly Balance Sheets Chart
Quarterly
|
Annual
Kaleyra . Quarterly Balance Sheets Table
Quarterly
|
Annual
Unit: USD | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-09-30 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
assets | |||||||||||||||||||
current assets: | |||||||||||||||||||
cash and cash equivalents | 63,866,000 | 74,362,000 | 77,500,000 | 86,536,000 | 73,622,000 | 86,222,000 | 90,001,000 | 70,303,000 | 118,625,000 | 35,507,000 | 32,970,000 | 31,514,000 | 37,221,000 | 16,237,000 | 16,103,000 | ||||
restricted cash | 488,000 | 488,000 | 480,000 | 439,000 | 468,000 | 1,667,000 | 1,701,000 | 1,738,000 | 27,000 | 20,810,000 | 20,894,000 | ||||||||
short-term investments | 630,000 | 637,000 | 587,000 | 622,000 | 680,000 | 7,294,000 | 6,236,000 | 36,447,000 | 6,099,000 | 4,287,000 | 4,843,000 | 5,138,000 | 4,805,000 | 3,079,000 | |||||
trade receivables | 73,653,000 | 82,948,000 | 86,783,000 | 85,863,000 | 95,768,000 | 82,038,000 | 85,945,000 | 82,749,000 | 77,252,000 | 41,611,000 | 43,651,000 | 40,006,000 | 38,069,000 | 36,307,000 | 39,509,000 | ||||
deferred cost | 354,000 | 334,000 | 319,000 | 347,000 | 329,000 | 319,000 | 341,000 | ||||||||||||
prepaid expenses | 3,451,000 | 3,764,000 | 3,989,000 | 3,466,000 | 4,340,000 | 4,718,000 | 5,357,000 | 3,444,000 | 3,850,000 | 1,233,000 | 1,447,000 | 1,227,000 | 1,098,000 | 1,246,000 | 648,000 | 11,462 | 31,982 | 45,836 | 110,439 |
other current assets | 4,748,000 | 3,944,000 | 3,387,000 | 1,966,000 | 1,436,000 | 1,662,000 | 2,599,000 | 4,408,000 | 3,668,000 | 5,222,000 | 2,134,000 | 1,774,000 | 1,921,000 | 2,757,000 | 4,224,000 | ||||
total current assets | 147,190,000 | 166,477,000 | 173,045,000 | 179,239,000 | 176,643,000 | 183,920,000 | 192,180,000 | 199,419,000 | 209,865,000 | 87,860,000 | 85,045,000 | 79,659,000 | 83,141,000 | 80,436,000 | 86,502,000 | 488,115 | 368,173 | 183,183 | 713,936 |
property and equipment | 23,535,000 | 23,840,000 | 23,826,000 | 21,107,000 | 20,384,000 | 19,824,000 | 18,811,000 | 17,203,000 | 15,939,000 | 7,113,000 | 6,726,000 | 5,825,000 | 4,750,000 | 3,888,000 | 3,393,000 | ||||
operating right-of-use assets | 2,599,000 | 2,781,000 | 2,931,000 | ||||||||||||||||
intangible assets | 52,678,000 | 55,229,000 | 57,400,000 | 110,009,000 | 115,146,000 | 120,575,000 | 125,396,000 | 130,085,000 | 133,525,000 | 7,156,000 | 7,574,000 | 7,937,000 | 8,229,000 | 8,665,000 | 9,353,000 | ||||
goodwill | 111,905,000 | 111,801,000 | 111,526,000 | 110,781,000 | 111,893,000 | 110,088,000 | 110,465,000 | 110,657,000 | 96,788,000 | 16,612,000 | 16,657,000 | 16,558,000 | 16,296,000 | 16,370,000 | 16,953,000 | ||||
other long-term assets | 2,219,000 | 1,995,000 | 1,445,000 | 1,740,000 | 1,525,000 | 1,464,000 | 399,000 | 395,000 | 313,000 | 299,000 | 1,797,000 | 1,783,000 | 1,700,000 | 2,082,000 | 1,203,000 | ||||
total assets | 340,126,000 | 362,123,000 | 370,173,000 | 423,383,000 | 425,967,000 | 436,409,000 | 448,481,000 | 457,759,000 | 456,430,000 | 119,080,000 | 118,502,000 | 111,762,000 | 114,116,000 | 111,441,000 | 117,404,000 | 79,366,258 | 78,361,971 | 147,720,523 | 145,899,402 |
liabilities and stockholders’ equity | |||||||||||||||||||
current liabilities: | |||||||||||||||||||
accounts payable | 73,038,000 | 80,331,000 | 82,258,000 | 75,840,000 | 71,934,000 | 69,209,000 | 70,942,000 | 74,692,000 | 66,765,000 | 46,135,000 | 51,768,000 | 48,076,000 | 55,152,000 | 56,674,000 | 63,320,000 | 1,391,723 | 1,275,461 | 1,220,538 | 64,581 |
lines of credit | 3,468,000 | 2,991,000 | 3,955,000 | 3,255,000 | 3,182,000 | 4,649,000 | 5,256,000 | 5,464,000 | 5,338,000 | 4,439,000 | 5,273,000 | 4,567,000 | 4,995,000 | 5,278,000 | |||||
current portion of notes payable | 405,000 | 405,000 | 405,000 | 405,000 | |||||||||||||||
current portion of bank and other borrowings | 9,389,000 | 10,234,000 | 11,419,000 | 10,468,000 | 10,581,000 | 10,657,000 | 10,508,000 | 10,455,000 | 9,448,000 | 8,082,000 | 10,798,000 | 9,675,000 | 8,082,000 | 5,925,000 | 11,243,000 | ||||
deferred revenue | 2,443,000 | 3,290,000 | 3,528,000 | 5,283,000 | 6,934,000 | 6,778,000 | 9,553,000 | 11,055,000 | 10,775,000 | 3,107,000 | 3,666,000 | 1,519,000 | 1,500,000 | 1,538,000 | 1,397,000 | ||||
payroll and payroll related accrued liabilities | 6,855,000 | 7,371,000 | 5,993,000 | 7,643,000 | 6,567,000 | 8,908,000 | 6,907,000 | 5,450,000 | 4,124,000 | 3,374,000 | 3,292,000 | 3,819,000 | 5,267,000 | 2,929,000 | 1,038,000 | ||||
other current liabilities | 10,644,000 | 14,502,000 | 9,431,000 | 9,078,000 | 6,327,000 | 8,813,000 | 8,274,000 | 8,879,000 | 6,647,000 | 2,786,000 | 5,988,000 | 1,759,000 | 1,687,000 | 2,023,000 | 1,229,000 | 87,069 | 203,018 | 231,758 | 221,865 |
total current liabilities | 105,837,000 | 119,124,000 | 116,989,000 | 111,972,000 | 105,930,000 | 109,014,000 | 111,440,000 | 115,995,000 | 103,097,000 | 71,673,000 | 88,768,000 | 73,645,000 | 93,960,000 | 121,127,000 | 125,946,000 | 5,792,639 | 4,227,619 | 3,291,782 | 1,059,286 |
long-term portion of bank and other borrowings | 9,494,000 | 11,675,000 | 13,459,000 | 14,488,000 | 15,928,000 | 19,988,000 | 22,910,000 | 26,574,000 | 28,611,000 | 31,020,000 | 31,974,000 | 33,462,000 | 18,755,000 | 20,621,000 | 16,134,000 | ||||
long-term portion of notes payable | 192,844,000 | 192,293,000 | 191,777,000 | 191,240,000 | 190,733,000 | 190,625,000 | 190,147,000 | 189,647,000 | 189,238,000 | 405,000 | 2,700,000 | 2,700,000 | 2,700,000 | ||||||
long-term portion of employee benefit obligation | 2,380,000 | 2,359,000 | 2,373,000 | 2,301,000 | 2,377,000 | 2,393,000 | 2,338,000 | 2,158,000 | 1,952,000 | 1,886,000 | 1,886,000 | 1,641,000 | 1,490,000 | 1,341,000 | 1,398,000 | ||||
other long-term liabilities | 3,193,000 | 3,052,000 | 3,362,000 | 785,000 | 892,000 | 1,253,000 | 1,840,000 | 2,004,000 | 1,667,000 | 2,158,000 | 603,000 | 1,335,000 | 1,147,000 | 4,599,000 | 3,155,000 | ||||
total liabilities | 313,748,000 | 328,503,000 | 327,960,000 | 326,842,000 | 321,065,000 | 326,029,000 | 331,059,000 | 338,780,000 | 326,357,000 | 107,142,000 | 125,931,000 | 117,626,000 | 123,106,000 | 153,076,000 | 156,178,000 | ||||
commitments and contingencies | |||||||||||||||||||
stockholders’ equity: | |||||||||||||||||||
preferred stock, par value of 0.0001 per share; 1,000,000 shares authorized; no shares issued or outstanding | |||||||||||||||||||
common stock | 1,000 | 1,000 | 1,000 | 5,000 | 5,000 | 4,000 | 4,000 | 4,000 | 4,000 | 3,000 | 3,000 | 3,000 | 3,000 | 2,000 | 2,000 | 445 | 440 | 419 | 415 |
additional paid-in capital | 282,459,000 | 280,486,000 | 278,473,000 | 275,129,000 | 270,672,000 | 258,418,000 | 251,659,000 | 246,205,000 | 245,452,000 | 122,252,000 | 93,628,000 | 89,574,000 | 74,284,000 | 11,190,000 | 2,143,000 | 6,751,086 | 6,190,351 | 6,076,342 | 5,664,971 |
treasury stock | -30,431,000 | -30,431,000 | -30,431,000 | -30,431,000 | -30,431,000 | -30,431,000 | -30,431,000 | -30,431,000 | -30,431,000 | -30,431,000 | -30,431,000 | -30,431,000 | -24,218,000 | -2,587,000 | |||||
accumulated other comprehensive loss | -4,710,000 | -4,584,000 | -5,212,000 | -5,679,000 | -4,535,000 | -2,639,000 | -2,010,000 | -2,292,000 | -2,304,000 | -1,725,000 | |||||||||
accumulated deficit | -220,941,000 | -211,852,000 | -200,618,000 | -142,483,000 | -130,809,000 | -114,972,000 | -101,800,000 | -94,507,000 | -82,648,000 | -78,161,000 | -67,803,000 | -63,277,000 | -57,944,000 | -49,816,000 | -40,993,000 | -1,751,523 | -1,190,790 | -1,076,760 | -665,385 |
total stockholders’ equity | 26,378,000 | 33,620,000 | 42,213,000 | 96,541,000 | 104,902,000 | 110,380,000 | 117,422,000 | 118,979,000 | 130,073,000 | 11,938,000 | -7,429,000 | -5,864,000 | -8,990,000 | -41,635,000 | -38,774,000 | 5,000,008 | 5,000,001 | 5,000,001 | 5,000,001 |
total liabilities and stockholders’ equity | 340,126,000 | 362,123,000 | 370,173,000 | 423,383,000 | 425,967,000 | 436,409,000 | 448,481,000 | 457,759,000 | 456,430,000 | 119,080,000 | 118,502,000 | 111,762,000 | 114,116,000 | 111,441,000 | 117,404,000 | 79,366,258 | 78,361,971 | 147,720,523 | 145,899,402 |
deferred tax assets | 507,000 | 376,000 | 538,000 | 1,230,000 | 40,000 | 703,000 | |||||||||||||
deferred tax liabilities | 6,056,000 | 5,205,000 | 2,756,000 | 2,384,000 | 1,093,000 | 1,304,000 | 1,638,000 | 2,045,000 | |||||||||||
stockholders’ equity | |||||||||||||||||||
debt for forward share purchase agreements | 483,000 | 480,000 | 7,525,000 | 31,530,000 | 34,059,000 | ||||||||||||||
notes payable due to related parties | 3,750,000 | 7,500,000 | 3,750,000 | 9,750,000 | 13,115,000 | 9,414,000 | |||||||||||||
deferred costs | 330,000 | 371,000 | |||||||||||||||||
deferred tax liability | 2,402,000 | 1,792,000 | |||||||||||||||||
notes payable | 2,113,000 | 1,716,000 | 1,437,500 | ||||||||||||||||
preference shares | 1,000 | 1,000 | 683,000 | ||||||||||||||||
preference shares due to related parties | 1,000 | 1,000 | 1,847,000 | ||||||||||||||||
long-term portion of notes payable due to related parties | 3,750,000 | 3,750,000 | 3,750,000 | 7,500,000 | |||||||||||||||
accumulated other comprehensive income | -2,826,000 | -1,733,000 | -1,115,000 | -424,000 | 74,000 | ||||||||||||||
short-term marketable securities | 5,124,000 | ||||||||||||||||||
deferred consideration for the acquisition | |||||||||||||||||||
deferred consideration for the acquisition due to related parties | |||||||||||||||||||
long-term portion of preference shares | |||||||||||||||||||
long-term portion of preference shares due to related parties | |||||||||||||||||||
deferred consideration for the acquisitions | |||||||||||||||||||
deferred consideration for the acquisitions due to related parties | |||||||||||||||||||
current assets | |||||||||||||||||||
cash | 469,707 | 329,245 | 137,347 | 597,268 | |||||||||||||||
receivable from related party | 6,946 | 6,946 | 6,229 | ||||||||||||||||
cash and marketable securities held in trust account | 78,757,615 | 77,838,232 | 147,256,712 | 144,964,309 | |||||||||||||||
interest receivable on cash and marketable securities held in trust account | 120,528 | 155,566 | 280,628 | 221,157 | |||||||||||||||
current liabilities | |||||||||||||||||||
payable to related party | 123,421 | 44,119 | 19,922 | ||||||||||||||||
notes payable to founders | 3,050,426 | 2,074,099 | |||||||||||||||||
accrued liabilities | 1,140,000 | 630,922 | 382,064 | 772,840 | |||||||||||||||
common stock subject to possible redemption, 7,182,567 and 14,309,217 shares as of september 30, 2019 and 2018, respectively, at a redemption value of 10.00 per share | 68,573,611 | ||||||||||||||||||
preferred stock, par value of 0.0001 per share; 1,000,000 shares authorized; none issued or outstanding | |||||||||||||||||||
common stock subject to possible redemption, 7,238,641 and 14,309,217 shares as of june 30, 2019 and september 30, 2018, respectively, at a redemption value of 10.00 per share | 69,134,351 | ||||||||||||||||||
common stock subject to possible redemption, 14,268,080 and 14,309,217 shares as of march 31, 2019 and september 30, 2018, respectively, at a redemption value of 10.00 per share | 139,428,740 | ||||||||||||||||||
common stock subject to possible redemption, 14,309,217 shares at a redemption value of 10.00 per share | 139,840,115 |
We provide you with 20 years of balance sheets for Kaleyra . stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Kaleyra .. Explore the full financial landscape of Kaleyra . stock with our expertly curated balance sheets.
The information provided in this report about Kaleyra . stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.